suPARnostic® TurbiLatex

suPAR is the soluble form of urokinase Plasminogen Activator Receptor (uPAR). The amount of suPAR is a measure of immune activation and inflammation. suPAR is a biomarker increased by disease presence and severity

Important clinical benefits include;

  • Aid in prioritization of patients who can be discharged after treatment
  • Assistance in the identification of high-risk patients with unaffected vital signs
  • Shortens the average patient-length-of-stay and reduces the cost of healthcare

The suPARnostic® TurbiLatex product is CE-IVD approved and validated on the Roche Diagnostics Cobas c111, c303, c501/2, c701/2, Pure and Pro systems, the Siemens Atellica, and ADVIA Chemistry XPT, the Abbott Architect c, and Alinity ci systems and Beckman Coulter 5800.

Overview

The suPARnostic® TurbiLatex test is a latex particle-enhanced turbidimetric immunoassay that quantitatively determines the suPAR level in human K2-EDTA- or Lithium Heparin plasma samples.

The suPARnostic® TurbiLatex product is validated for the Roche Diagnostics Cobas c111, c303, c501/2, c701/2, Pure and Pro systems, the Siemens Atellica, and ADVIA Chemistry XPT, the Abbott Architect c, and Alinity ci systems and Beckman Coulter 5800.

Products contain

  • Reagent 1: Dilution Buffer
  • Reagent 2: Latex Particles coated with anti-suPAR antibodies

Benefits

  • Ready-to-use reagents
  • Automated, high throughput operation
  • Timely results
  • LIS connectivity

Product Code

Product no.Product nameAnalyserNo. of tests
T004suPARnostic® TurbiLatex Reagents for c 501/2Roche cobas120
T005suPARnostic® TurbiLatex Reagents for c 701/2Roche cobas420
T006suPARnostic® TurbiLatex ReagentsSiemens ADVIA XPT200
T008suPARnostic® TurbiLatex ReagentsAbbott Architect90
T009suPARnostic® TurbiLatex ReagentsAbbott Architect250
T010suPARnostic® TurbiLatex ReagentsAbbott Alinity150
T011suPARnostic® TurbiLatex ReagentsAbbott Alinity300
T012suPARnostic® TurbiLatex ReagentsSiemens Atellica200

Price Quote

Contact us at sales@virogates.com

Documentation

See technical documents

Overview

Quality control of the suPARnostic® TurbiLatex Reagents should be performed with the suPARnostic® TurbiLatex Controls.

Quality control should be performed according to the laboratory guidelines. Ranges and limits should be fitted to the specific laboratory’s experience and knowledge.

Product contains

  • 1 mL of each Control 1-3 (Low, Medium, High suPAR level)
  • Certificate of analysis with concentrations is provided with each kit

Product Code

T003: suPARnostic® TurbiLatex Controls

Price Quote

Contact us at sales@virogates.com

Documentation

See technical documents

Overview

Together with the suPARnostic® TurbiLatex Reagents, the suPARnostic® TurbiLatex Calibrators should be used for calibration.

It is recommended to repeat the calibration at least once a month. In addition, it is required to recalibrate when a new batch of the suPARnostic® TurbiLatex Reagents is used.

The suPARnostic® Calibrators are used to establish a calibration curve which is used to interpolate the suPAR measurements.

The product contains

  • 1 mL of each Calibrator
    #T007 contains a Blank calibratorCertificate of analysis with concentrations is provided with each kit

Product Code

Product no. T002: suPARnostic® TurbiLatex Calibrators for Roche Cobas systems
Product no. T007: suPARnostic® TurbiLatex Calibrators for Siemens and Abbott systems

Price Quote

Contact us at sales@virogates.com

Documentation

See technical documents

Want to buy suPARnostic®?

900+

published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of 3 products:

Photo of The suPARnostic® Quick Triage kit

Quick Triage

A Point of Care Solution

Photo of suPARnostic® TurbiLatex

TurbiLatex

For Automated Systems

Photo of suPARnostic® ELISA

ELISA Assay

Clinical and Research

suPAR is used in clinical routine in 38 hospitals

38 hospitals use suPAR in clinical routine for triage of patients in the Emergency Departments and COVID-19 units. Clinical routine is defined by the placement of two Purchasing Orders within the last 12 months rolling. This period covers October 1, 2021, until September 30, 2022.
Some hospital locations cannot be disclosed due to confidentiality.

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates